Friday, November 26, 2004
Many See Hope in Parkinson's Drug Pulled From Testing
"If a company stops developing a drug for safety or efficacy reasons, is it obligated to continue supplying it to patients from its clinical trials?"
"If a company stops developing a drug for safety or efficacy reasons, is it obligated to continue supplying it to patients from its clinical trials?"
Posted by Kevin |
link
| Comments (0)
| 
Comments: Post a Comment
